Cancer Genetics, Inc. (CGIX)

0.24
NASDAQ
Prev Close 0.24
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.20 / 1.30
Exchange NASDAQ
Shares Outstanding 56.28B
Market Cap 13.76M
Div & Yield N.A. (N.A)
Cancer Genetics, Inc. To Host Conference Call To Discuss Strategic And Business Rationale Of vivoPharm Acquisition

Cancer Genetics, Inc. To Host Conference Call To Discuss Strategic And Business Rationale Of vivoPharm Acquisition

Conference call scheduled for Tuesday, August 22, 2017- 8:30 AM Eastern

Liking the Look of Some of These Pullbacks

Liking the Look of Some of These Pullbacks

This corrective action has me feeling optimistic about some new opportunities.

Heck With the NFL Draft; I'm Anxiously Awaiting a Big Earnings Night

Heck With the NFL Draft; I'm Anxiously Awaiting a Big Earnings Night

Microsoft, Intel, Alphabet and Amazon are among the big-cap names that will report after the bell.

Don't Be Surprised If Dip Buyers Jump In on Any Pullback

Don't Be Surprised If Dip Buyers Jump In on Any Pullback

We'll see what happens in the way of reaction to Trump's tax policy this afternoon, but if we sell off I'm likely going to be a buyer.

The Best Timeframe Right Now Is the Intraday Trade

The Best Timeframe Right Now Is the Intraday Trade

Traders recognize that chasing doesn't work when there is so little momentum.

Health Care Vote Impacts Trump's Deal Maker Image

Health Care Vote Impacts Trump's Deal Maker Image

At stake is whether the Republicans can work out their differences.

TheStreet Quant Rating: D- (Sell)